DDX53 and neoplasm: In our study, mice that achieved complete tumor remission following anti-PD1 and CpG7909 lipoplex treatment showed no tumor recurrence upon CT26 rechallenge at day 144, well beyond the typical 60–120-day observation period in most murine tumor models.